Findings
What does this study add?
- Most women required insulin therapy (26/32, 81%).
- Baseline HbA1C levels were similar between groups.
- The glucose management indicator (GMI) was numerically similar to HbA1C for the T1D and GDM cohorts.
- Time spent with glucose levels >140 mg/dL (p=0.009) was highest and time in range (63-140 mg/dL) was lowest (p=0.001) in women with T1D compared to the other groups.
- The coefficient of variation (CV) and mean amplitude of glycemic excursions (MAGE) were highest in the T1D group, lowest in the GDM group, and intermediate in the T2D group (p <0.0001 for each).